{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:56Z","timestamp":1787003696012,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94049-3","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T14:06:08Z","timestamp":1742220368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nomogram model to predict the risk of moderate to severe ovarian hyperstimulation syndrome of long protocol group in fresh cycle"],"prefix":"10.1038","volume":"15","author":[{"given":"Huihui","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"94049_CR1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn101441-20230704-00261","author":"J Jiao","year":"2024","unstructured":"Jiao, J., Geng, C., Zhang, Y. & Cui, L. Research progress on the influencing factors and related mechanisms of birth weight in offspring of assisted reproductive technology. Chin. J. Reprod. Contracept. https:\/\/doi.org\/10.3760\/cma.j.cn101441-20230704-00261 (2024).","journal-title":"Chin. J. Reprod. Contracept."},{"key":"94049_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","volume":"8","author":"A Delvigne","year":"2002","unstructured":"Delvigne, A. & Rozenberg, S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update 8, 559\u2013577. https:\/\/doi.org\/10.1093\/humupd\/8.6.559 (2002).","journal-title":"Hum. Reprod. Update"},{"key":"94049_CR3","doi-asserted-by":"publisher","DOI":"10.19538\/j.fk2023100102","author":"Q Zhu","year":"2023","unstructured":"Zhu, Q. & Sun, L. Prevention and prevention of ovarian hyperstimulation syndrome. Chin. J. Practical Gynecol. Obstet. https:\/\/doi.org\/10.19538\/j.fk2023100102 (2023).","journal-title":"Chin. J. Practical Gynecol. Obstet."},{"key":"94049_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0140-6736(94)93001-5","volume":"344","author":"N McClure","year":"1994","unstructured":"McClure, N. et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344, 235\u2013236. https:\/\/doi.org\/10.1016\/s0140-6736(94)93001-5 (1994).","journal-title":"Lancet"},{"key":"94049_CR5","first-page":"248","volume":"43","author":"BM Namavar Jahromi","year":"2018","unstructured":"Namavar Jahromi, B. M. et al. Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran. J. Med. Sci. 43, 248\u2013260 (2018).","journal-title":"Iran. J. Med. Sci."},{"key":"94049_CR6","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1093\/humrep\/det303","volume":"28","author":"J Ji","year":"2013","unstructured":"Ji, J. et al. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum. Reprod. 28, 2728\u20132734. https:\/\/doi.org\/10.1093\/humrep\/det303 (2013).","journal-title":"Hum. Reprod."},{"issue":"Suppl 1","key":"94049_CR7","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/s0049-3848(17)30070-1","volume":"151","author":"SM Nelson","year":"2017","unstructured":"Nelson, S. M. Prevention and management of ovarian hyperstimulation syndrome. Thromb. Res. 151(Suppl 1), S61\u2013s64. https:\/\/doi.org\/10.1016\/s0049-3848(17)30070-1 (2017).","journal-title":"Thromb. Res."},{"key":"94049_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.fertnstert.2009.02.049","volume":"94","author":"PS Gera","year":"2010","unstructured":"Gera, P. S., Tatpati, L. L., Allemand, M. C., Wentworth, M. A. & Coddington, C. C. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome. Fertil. Steril. 94, 173\u2013178. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.049 (2010).","journal-title":"Fertil. Steril."},{"key":"94049_CR9","doi-asserted-by":"publisher","first-page":"0009","DOI":"10.34133\/hds.0009","volume":"3","author":"D Zheng","year":"2023","unstructured":"Zheng, D. et al. The incidence of moderate and severe ovarian hyperstimulation syndrome in hospitalized patients in China. Health Data Sci. 3, 0009. https:\/\/doi.org\/10.34133\/hds.0009 (2023).","journal-title":"Health Data Sci."},{"key":"94049_CR10","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil. Steril. 121, 230\u2013245. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.11.013 (2024).","DOI":"10.1016\/j.fertnstert.2023.11.013"},{"key":"94049_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","volume":"35","author":"B Xu","year":"2020","unstructured":"Xu, B. et al. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study. Hum. Reprod. 35, 1306\u20131318. https:\/\/doi.org\/10.1093\/humrep\/deaa086 (2020).","journal-title":"Hum. Reprod."},{"key":"94049_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1210\/er.2005-0015","volume":"27","author":"NS Macklon","year":"2006","unstructured":"Macklon, N. S., Stouffer, R. L., Giudice, L. C. & Fauser, B. C. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr. Rev. 27, 170\u2013207. https:\/\/doi.org\/10.1210\/er.2005-0015 (2006).","journal-title":"Endocr. Rev."},{"key":"94049_CR13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/s0140-6736(05)66478-1","volume":"365","author":"BC Fauser","year":"2005","unstructured":"Fauser, B. C., Devroey, P. & Macklon, N. S. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365, 1807\u20131816. https:\/\/doi.org\/10.1016\/s0140-6736(05)66478-1 (2005).","journal-title":"Lancet"},{"key":"94049_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","volume":"27","author":"CO Nastri","year":"2010","unstructured":"Nastri, C. O., Ferriani, R. A., Rocha, I. A. & Martins, W. P. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J. Assist. Reprod. Genet. 27, 121\u2013128. https:\/\/doi.org\/10.1007\/s10815-010-9387-6 (2010).","journal-title":"J. Assist. Reprod. Genet."},{"key":"94049_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward, R. G. et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil. Steril. 101, 967\u2013973. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.026 (2014).","journal-title":"Fertil. Steril."},{"key":"94049_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca, A. & Sunkara, S. K. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum. Reprod. Update. 20, 124\u2013140. https:\/\/doi.org\/10.1093\/humupd\/dmt037 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"94049_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/09513590.2013.875998","volume":"30","author":"MD Johnson","year":"2014","unstructured":"Johnson, M. D. et al. Relationship between human chorionic gonadotropin serum levels and the risk of ovarian hyperstimulation syndrome. Gynecol. Endocrinol. 30, 294\u2013297. https:\/\/doi.org\/10.3109\/09513590.2013.875998 (2014).","journal-title":"Gynecol. Endocrinol."},{"key":"94049_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10815-017-1074-4","volume":"35","author":"Y Anaya","year":"2018","unstructured":"Anaya, Y. et al. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone May decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols. J. Assist. Reprod. Genet. 35, 297\u2013307. https:\/\/doi.org\/10.1007\/s10815-017-1074-4 (2018).","journal-title":"J. Assist. Reprod. Genet."},{"key":"94049_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen, C. et al. Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and Cyclic follicle recruitment. Mol. Hum. Reprod. 10, 77\u201383. https:\/\/doi.org\/10.1093\/molehr\/gah015 (2004).","journal-title":"Mol. Hum. Reprod."},{"key":"94049_CR20","doi-asserted-by":"publisher","unstructured":"Themmen, A. P. Anti-M\u00fcllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J. Natl. Cancer Inst. Monogr. 2005, 18\u201321. https:\/\/doi.org\/10.1093\/jncimonographs\/lgi026 (2005).","DOI":"10.1093\/jncimonographs\/lgi026"},{"key":"94049_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca, A. et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update 16, 113\u2013130. https:\/\/doi.org\/10.1093\/humupd\/dmp036 (2010).","journal-title":"Hum. Reprod. Update"},{"key":"94049_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny, P., Jonard, S., Robert, Y. & Dewailly, D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 941\u2013945. https:\/\/doi.org\/10.1210\/jc.2005-2076 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94049_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","volume":"26","author":"A Aflatoonian","year":"2009","unstructured":"Aflatoonian, A., Oskouian, H., Ahmadi, S. & Oskouian, L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-M\u00fcllerian hormone versus small antral follicle count (2\u20136\u00a0mm). J. Assist. Reprod. Genet. 26, 319\u2013325. https:\/\/doi.org\/10.1007\/s10815-009-9319-5 (2009).","journal-title":"J. Assist. Reprod. Genet."},{"key":"94049_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee, T. H. et al. Serum anti-M\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum. Reprod. 23, 160\u2013167. https:\/\/doi.org\/10.1093\/humrep\/dem254 (2008).","journal-title":"Hum. Reprod."},{"key":"94049_CR25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/s0140-6736(03)14410-8","volume":"362","author":"LJ Webber","year":"2003","unstructured":"Webber, L. J. et al. Formation and early development of follicles in the polycystic ovary. Lancet 362, 1017\u20131021. https:\/\/doi.org\/10.1016\/s0140-6736(03)14410-8 (2003).","journal-title":"Lancet"},{"key":"94049_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt, L. et al. Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab. 92, 240\u2013245. https:\/\/doi.org\/10.1210\/jc.2006-1582 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94049_CR27","doi-asserted-by":"publisher","first-page":"77e71","DOI":"10.1016\/j.ajog.2006.07.046","volume":"196","author":"JG Wang","year":"2007","unstructured":"Wang, J. G., Nakhuda, G. S., Guarnaccia, M. M., Sauer, M. V. & Lobo, R. A. M\u00fcllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 196, 77e71\u201377e75. https:\/\/doi.org\/10.1016\/j.ajog.2006.07.046 (2007).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"94049_CR28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1210\/jc.2006-2425","volume":"92","author":"DS Wachs","year":"2007","unstructured":"Wachs, D. S., Coffler, M. S., Malcom, P. J. & Chang, R. J. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J. Clin. Endocrinol. Metab. 92, 1871\u20131874. https:\/\/doi.org\/10.1210\/jc.2006-2425 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94049_CR29","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/humrep\/deg451","volume":"18","author":"J Bellver","year":"2003","unstructured":"Bellver, J. et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum. Reprod. 18, 2283\u20132288. https:\/\/doi.org\/10.1093\/humrep\/deg451 (2003).","journal-title":"Hum. Reprod."},{"key":"94049_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/oxfordjournals.humrep.a137276","volume":"6","author":"RH Asch","year":"1991","unstructured":"Asch, R. H., Li, H. P., Balmaceda, J. P., Weckstein, L. N. & Stone, S. C. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum. Reprod. 6, 1395\u20131399. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137276 (1991).","journal-title":"Hum. Reprod."},{"key":"94049_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/humupd\/dmg018","volume":"9","author":"MA Aboulghar","year":"2003","unstructured":"Aboulghar, M. A. & Mansour, R. T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum. Reprod. Update. 9, 275\u2013289. https:\/\/doi.org\/10.1093\/humupd\/dmg018 (2003).","journal-title":"Hum. Reprod. Update"},{"key":"94049_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/humupd\/dmn008","volume":"14","author":"SR Soares","year":"2008","unstructured":"Soares, S. R., G\u00f3mez, R., Sim\u00f3n, C., Garc\u00eda-Velasco, J. A. & Pellicer, A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum. Reprod. Update. 14, 321\u2013333. https:\/\/doi.org\/10.1093\/humupd\/dmn008 (2008).","journal-title":"Hum. Reprod. Update"},{"issue":"Suppl 1","key":"94049_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/09513590.2014.945780","volume":"30","author":"NV Bachmakova","year":"2014","unstructured":"Bachmakova, N. V. et al. The development of ovarian hyperstimulation syndrome in the implementation of assisted reproductive technology in women with a background of endocrine pathology. Gynecol. Endocrinol. 30 (Suppl 1), 25\u201329. https:\/\/doi.org\/10.3109\/09513590.2014.945780 (2014).","journal-title":"Gynecol. Endocrinol."},{"key":"94049_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fertnstert.2021.01.029","volume":"116","author":"A Busnelli","year":"2021","unstructured":"Busnelli, A., Cirillo, F. & Levi-Setti, P. E. Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis. Fertil. Steril. 116, 218\u2013231. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.01.029 (2021).","journal-title":"Fertil. Steril."},{"key":"94049_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1210\/jcem.85.2.6374","volume":"85","author":"AF Muller","year":"2000","unstructured":"Muller, A. F., Verhoeff, A., Mantel, M. J., De Jong, F. H. & Berghout, A. Decrease of free thyroxine levels after controlled ovarian hyperstimulation. J. Clin. Endocrinol. Metab. 85, 545\u2013548. https:\/\/doi.org\/10.1210\/jcem.85.2.6374 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94049_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/er.2009-0007","volume":"31","author":"SY Cheng","year":"2010","unstructured":"Cheng, S. Y., Leonard, J. L. & Davis, P. J. Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139\u2013170. https:\/\/doi.org\/10.1210\/er.2009-0007 (2010).","journal-title":"Endocr. Rev."},{"key":"94049_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0301-2115(03)00283-5","volume":"112","author":"BM Taher","year":"2004","unstructured":"Taher, B. M. et al. Spontaneous ovarian hyperstimulation syndrome caused by hypothyroidism in an adult. Eur. J. Obstet. Gynecol. Reprod. Biol. 112, 107\u2013109. https:\/\/doi.org\/10.1016\/s0301-2115(03)00283-5 (2004).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"94049_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/00016340500324571","volume":"85","author":"F Guvenal","year":"2006","unstructured":"Guvenal, F., Guvenal, T., Timuroglu, Y., Timuroglu, T. & Cetin, M. Spontaneous ovarian hyperstimulation-like reaction caused by primary hypothyroidism. Acta Obstet. Gynecol. Scand. 85, 124\u2013125. https:\/\/doi.org\/10.1080\/00016340500324571 (2006).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"94049_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5468\/ogs.2014.57.6.507","volume":"57","author":"YJ Lee","year":"2014","unstructured":"Lee, Y. J. et al. Subclinical hypothyroidism diagnosed by thyrotropin-releasing hormone stimulation test in infertile women with basal thyroid-stimulating hormone levels of 2.5 to 5.0 mIU\/L. Obstet. Gynecol. Sci. 57, 507\u2013512. https:\/\/doi.org\/10.5468\/ogs.2014.57.6.507 (2014).","journal-title":"Obstet. Gynecol. Sci."},{"key":"94049_CR40","doi-asserted-by":"publisher","unstructured":"Zhou, J. et al. Ovarian hyperstimulation syndrome combined with hypothyroidism: a comprehensive review. J. Ovarian Res. 17, 896. https:\/\/doi.org\/10.1186\/s13048-024-01406-3 (2024).","DOI":"10.1186\/s13048-024-01406-3"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94049-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T14:06:12Z","timestamp":1742220372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94049-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94049"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94049-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Zhengzhou University (KY2024218). The study was performed in accordance with the ethical standards as laid out in the 1964 Declaration of Helsinki. Written informed consent was obtained from individual participants or their guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9211"}}